Gorman Kevin Charles has been a registered insider since 2003.
As Chief Executive Officer at Neurocrine Biosciences, Inc., Gorman Kevin Charles last made a transaction on 2/8/2023.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 4 |
75% |
42% |
50% |
95 |
1 Year |
4 |
0% |
-- |
-- |
-- |
| 4 |
75% |
31% |
34% |
79 |
9 Month |
4 |
0% |
-- |
-- |
-- |
| 4 |
75% |
7% |
16% |
55 |
6 Month |
4 |
0% |
-- |
-- |
-- |
| 4 |
100% |
18% |
20% |
19 |
3 Month |
4 |
0% |
-- |
-- |
-- |
| 4 |
75% |
5% |
5% |
10 |
1 Month |
4 |
0% |
-- |
-- |
-- |
| 4 |
50% |
0% |
-0% |
7 |
1 Week |
4 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 37 |
41% |
23% |
17% |
285 |
1 Year |
37 |
0% |
-- |
-- |
-- |
| 37 |
43% |
25% |
10% |
275 |
9 Month |
37 |
0% |
-- |
-- |
-- |
| 37 |
32% |
18% |
11% |
191 |
6 Month |
37 |
0% |
-- |
-- |
-- |
| 39 |
41% |
9% |
5% |
108 |
3 Month |
39 |
0% |
-- |
-- |
-- |
| 39 |
44% |
2% |
2% |
53 |
1 Month |
39 |
0% |
-- |
-- |
-- |
| 39 |
56% |
0% |
-1% |
33 |
1 Week |
39 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/14/2023 01:32 PM EST |
Latest Transaction Date: |
2/8/2023 |
| Average days between Transaction and Entered Dates: |
2 |
